Cumberland Pharmaceuticals (CPIX) Retained Earnings (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Retained Earnings for 16 consecutive years, with -$26.8 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 11.83% to -$26.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$26.8 million through Dec 2025, down 11.83% year-over-year, with the annual reading at -$26.8 million for FY2025, 11.83% down from the prior year.
- Retained Earnings hit -$26.8 million in Q4 2025 for Cumberland Pharmaceuticals, down from -$25.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$735625.0 in Q2 2021 to a low of -$26.8 million in Q4 2025.
- Historically, Retained Earnings has averaged -$14.0 million across 5 years, with a median of -$11.2 million in 2022.
- Biggest YoY gain for Retained Earnings was 3.9% in 2021; the steepest drop was 1385.67% in 2021.
- Year by year, Retained Earnings stood at -$5.6 million in 2021, then crashed by 98.79% to -$11.2 million in 2022, then tumbled by 56.02% to -$17.5 million in 2023, then tumbled by 37.05% to -$24.0 million in 2024, then decreased by 11.83% to -$26.8 million in 2025.
- Business Quant data shows Retained Earnings for CPIX at -$26.8 million in Q4 2025, -$25.4 million in Q3 2025, and -$23.5 million in Q2 2025.